FDA 483 - Vericel Corporation
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Vericel Corporation in Burlington, MA, was inspected from February 2-6, 2026, and received a Form 483. The inspection revealed significant deficiencies in aseptic processing practices and procedures for MACI drug product manufacturing. Operators were observed compromising aseptic conditions by exiting and re-entering biological safety cabinets without proper garment changes, and the firm's SOPs lacked critical detail regarding personnel hygiene and cleanroom practices.
- Company
- Vericel Corporation
- Product Type
- Biologics
ID · e23ab23c-6b82-431f-876d-b8deb9b9509b